Mante, Friend Rezel C.
HRN: 20-42-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
MUPIROCIN 2%, 15G (TUBE)
03/28/2024
04/04/2024
TOPICAL
15g
BID
Phlebitis
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes